Recent research have the potential of RMP1-14, a specifically engineered anti-mouse PD-1 therapeutic, for enhancing malignant immune response . Unlike existing approaches, RMP1-14 exhibits superior https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14